635
Views
18
CrossRef citations to date
0
Altmetric
Gastroenterology

Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study

&
Pages 751-755 | Received 30 Aug 2017, Accepted 16 Jan 2018, Published online: 02 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Gabrio Bassotti, Paolo Usai Satta, Ginevra Berti, Mariantonia Lai, Vincenzo Villanacci & Massimo Bellini. (2022) Pharmacotherapeutic advances for chronic idiopathic constipation in adults. Expert Opinion on Pharmacotherapy 23:18, pages 2053-2078.
Read now
Philip B Miner. (2020) Plecanatide for the treatment of constipation-predominant irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 14:2, pages 71-84.
Read now
Amol Sharma, Anam Asif Herekar, Jigar Bhagatwala & Satish SC Rao. (2019) Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy. Clinical and Experimental Gastroenterology 12, pages 31-36.
Read now
Gabrio Bassotti, Paolo Usai Satta & Massimo Bellini. (2019) Plecanatide for the treatment of chronic idiopathic constipation in adult patients. Expert Review of Clinical Pharmacology 12:11, pages 1019-1026.
Read now
Charles F. Barish, Robert A. Crozier & Patrick H. Griffin. (2019) Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation. Current Medical Research and Opinion 35:1, pages 81-85.
Read now

Articles from other publishers (13)

Anna de Geus, Ilan J. N. Koppen, Robert B. Flint, Marc A. Benninga & Merit M. Tabbers. (2023) An Update of Pharmacological Management in Children with Functional Constipation. Pediatric Drugs.
Crossref
Pouyan Ghaffari, Saeed Shoaie & Lars K. Nielsen. (2022) Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions. Journal of Translational Medicine 20:1.
Crossref
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann & C. Pehl. (2022) Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019. Zeitschrift für Gastroenterologie 60:10, pages 1528-1572.
Crossref
Sophie Brigstocke, Vanessa Yu & Judy Nee. (2022) Review of the Safety Profiles of Laxatives in Pregnant Women. Journal of Clinical Gastroenterology 56:3, pages 197-203.
Crossref
Michael Camilleri. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 76 99 .
Maura Corsetti, Steven Brown, Giuseppe Chiarioni, Eirini Dimidi, Thomas Dudding, Anton Emmanuel, Mark Fox, Alexander C. Ford, Pasquale Giordano, Ugo Grossi, Michelle Henderson, Charles H. Knowles, P. Ronan O’Connell, Eamonn M. M. Quigley, Magnus Simren, Robin Spiller, Kevin Whelan, William E. Whitehead, Andrew B. Williams & S. Mark Scott. (2021) Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment. Neurogastroenterology & Motility 33:7.
Crossref
Amol Sharma, Satish S. C. Rao, Kimberly Kearns, Kimberly D. Orleck & Scott A. Waldman. (2021) Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders. Alimentary Pharmacology & Therapeutics 53:12, pages 1250-1267.
Crossref
Michael Camilleri. (2021) Diagnosis and Treatment of Irritable Bowel Syndrome. JAMA 325:9, pages 865.
Crossref
Mana H. Vriesman, Ilan J. N. Koppen, Michael Camilleri, Carlo Di Lorenzo & Marc A. Benninga. (2019) Management of functional constipation in children and adults. Nature Reviews Gastroenterology & Hepatology 17:1, pages 21-39.
Crossref
Philip B. MinerJr.Jr.. (2019) Benefit–Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation. Drug Safety 42:5, pages 603-615.
Crossref
Hannah A. Blair. (2018) Plecanatide in chronic idiopathic constipation and irritable bowel syndrome with constipation: a profile of its use in the USA. Drugs & Therapy Perspectives 34:12, pages 554-559.
Crossref
Nicole Martinez de Andino. (2018) Current treatment paradigm and landscape for the management of chronic idiopathic constipation in adults: Focus on plecanatide. Journal of the American Association of Nurse Practitioners 30:7, pages 412-420.
Crossref
David O. Prichard & Adil E. Bharucha. (2018) Recent advances in understanding and managing chronic constipation. F1000Research 7, pages 1640.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.